Related Experiment Videos
[Liver transplantation and tuberculosis]
1Department of Transplantation and Immunology, Kyoto University Faculty of Medicine, Japan.
Kekkaku : [Tuberculosis]
|February 24, 2001
Summary
Post-transplant tuberculosis poses significant risks for liver recipients, especially during immunosuppression and rejection treatment. Developing effective screening and evidence-based treatment guidelines is crucial for managing this complication.
Area of Science:
- Medical Science
- Immunology
- Infectious Diseases
Context:
- Liver transplantation indications have expanded in Japan for adult patients.
- Post-transplant tuberculosis (TB) management in liver recipients remains a challenge due to limited experience.
- Patients on immunosuppressants post-transplantation face heightened TB risk, comparable to lung recipients.
Purpose:
- To highlight the challenges and needs in managing tuberculosis following liver transplantation.
- To underscore the risks associated with immunosuppression and rejection treatment.
- To emphasize the necessity for improved diagnostic and treatment strategies.
Summary:
- Liver transplant recipients under immunosuppression are at high risk for tuberculosis.
- Rejection treatment exacerbates TB risks, including infection, dissemination, and mortality.
- Managing post-transplant TB is complicated by drug-induced liver injury, drug interactions, and increased rejection susceptibility.
Impact:
- Identifies critical obstacles in treating post-transplant tuberculosis.
- Stresses the urgent need for evidence-based consensus on diagnosis and treatment.
- Calls for the establishment of rapid and reliable screening methods for organ donors to prevent TB transmission.